InMed Reports Second Quarter Fiscal 2026 Financial Results and Provides Business Update
Vancouver, British Columbia--(Newsfile Corp. - February 11, 2026) - InMed Pharmaceuticals Inc. (NASDAQ: INM) ("InMed" or the "Company"), a pharmaceutical...
Vancouver, British Columbia--(Newsfile Corp. - February 11, 2026) - InMed Pharmaceuticals Inc. (NASDAQ: INM) ("InMed" or the "Company"), a pharmaceutical...
The Company reported revenue of $3.0 million in the Reported Period, compared to $2.7 million in the Comparable Period. During...
The trade war is renewed The United States appears to be moving toward sustained, very high tariffs. The three trade...
CHICAGO, June 23, 2025--(BUSINESS WIRE)--Veradigm® (OTCMKTS: MDRX), a leading provider of healthcare data and technology solutions, is providing an update...
Despite recent challenges in bond and equity markets, President Trump recently said that he will impose a 50% tariff on...
____________________1 Potential first-in-class radioenhancer “NBTXR3” was licensed to Johnson & Johnson by Nanobiotix in 2023 and renamed “JNJ-1900” for the...